Merck Resolves $220M Vioxx Loss Claims In 5th Circ.
Merck & Co. Inc. reached a tentative settlement Saturday in a proposed $220 million class action over economic losses allegedly caused by Vioxx, potentially ending a Fifth Circuit battle over whether...To view the full article, register now.
Already a subscriber? Click here to view full article